Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis

Sirolimus has emerged as an alternative to calcineurin inhibitors‐based (CNI) graft‐versus‐host disease (GVHD) prophylaxis. This retrospective study compares the outcome of 133 consecutive adult patients with haematological malignancies undergoing haploidentical stem cell transplantation with posttr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernani, Rafael, Piñana, José Luis, Pérez, Ariadna, Quintero, Abdiel, Montoro, Juan, Hernández‐Boluda, Juan C., Carretero, Carlos, Balaguer‐Roselló, Aitana, Guerreiro, Manuel, Lorenzo, Ignacio, Aguilar, Cristóbal, Giménez, Estela, Navarro, David, Sanz, Miguel A., Sanz, Jaime, Solano, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Transplant and Cellular Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175741/
https://www.ncbi.nlm.nih.gov/pubmed/35845283
http://dx.doi.org/10.1002/jha2.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175741/
https://www.ncbi.nlm.nih.gov/pubmed/35845283
http://dx.doi.org/10.1002/jha2.183

Ejemplares similares